citalopram has been researched along with piperidines in 77 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (22.08) | 18.7374 |
| 1990's | 13 (16.88) | 18.2507 |
| 2000's | 22 (28.57) | 29.6817 |
| 2010's | 22 (28.57) | 24.3611 |
| 2020's | 3 (3.90) | 2.80 |
| Authors | Studies |
|---|---|
| Mellerup, ET; Plenge, P | 2 |
| Laursen, H; Mellerup, ET; Plenge, P | 2 |
| Bengtsson, BO; Lundmark, J; Wålinder, J | 1 |
| Benkelfat, C; Galinowski, A; Lôo, H; Poirier, MF; Sechter, D; Suzini de Luca, H; Vanelle, JM | 1 |
| Insel, TR; Winslow, JT | 1 |
| Mellerup, ET; Nielsen, M; Plenge, P | 1 |
| Blier, P; Galzin, AM; Langer, SZ | 1 |
| Bäckström, I; Bergström, M; Marcusson, J | 1 |
| Andersson, A; Bäckström, I; Marcusson, JO | 1 |
| Esnaud, H; Graham, D; Habert, E; Langer, SZ | 1 |
| Galzin, AM; Langer, SZ; Moret, C; Verzier, B | 1 |
| Nowak, G; Pawłowski, L | 1 |
| Koshikawa, F; Koshikawa, N; Stephenson, JD | 1 |
| Fuller, RW | 1 |
| Asberg, M; Eriksson, B; Mårtensson, B; Träskman-Bendz, L; Wägner, A | 1 |
| Briley, M; Moret, C | 1 |
| Graham, D; Langer, SZ; Tahraoui, L | 1 |
| Bergström, M; Eriksson, K; Marcusson, JO; Ross, SB | 1 |
| Eriksson, K; Marcusson, J | 1 |
| Benkelfat, C; Gay, C; Léouffre, P; Löo, H; Poirier, MF | 1 |
| Pawłowski, L | 1 |
| Bolwig, TG; Clemmesen, L; Jensen, E; Min, SK; Rafaelsen, OJ | 1 |
| Constantinidis, J; Dick, P; Tissot, R | 1 |
| Hyttel, J; Sánchez, C | 1 |
| Dutta, AK; Madras, BK; Meltzer, PC; Reith, ME | 1 |
| Earley, B; Faherty, CJ; Leonard, BE | 1 |
| Stein, MB | 1 |
| Dutta, AK; Reith, ME; Xu, C | 1 |
| Hatanaka, K; Yamaguchi, T; Yatsugi, S | 2 |
| Jähkel, M; Oehler, J; Rilke, O; Will, K | 1 |
| Davis, MC; Dutta, AK; Reith, ME | 1 |
| Bharucha, A; Chew, ML; Huber, KA; Jacob, NJ; Kastango, KB; Marin, R; Mazumdar, S; Mulsant, BH; Pollock, BG; Rosen, J; Sweet, RA | 1 |
| Boot, JR; Broadmore, RJ; Cooper, J; Eyre, TA; Mitchell, SN; Pullar, IA; Sanger, GJ; Wedley, S | 1 |
| Audenaert, K; Blankaert, P; Dierckx, R; Gielen, I; Goethals, I; Hoybergs, Y; Otte, A; Peremans, K; van Heeringen, C; Vervaet, M | 1 |
| Grandoso, L; Pineda, J; Torrecilla, M; Ugedo, L | 1 |
| Ahs, F; Appel, L; Bani, M; Bergström, M; Flyckt, K; Fredrikson, M; Furmark, T; Grohp, M; Jacobsson, E; Långström, B; Michelgård, A; Nilsson, LG; Pich, EM; Wahlstedt, K; Zancan, S | 1 |
| Bourin, M; Chenu, F; Gardier, AM; Guiard, BP | 1 |
| Craig, DA; David, DJ; Dong, D; Gerald, CP; Hegde, LG; Hen, R; Holick, KA; Klemenhagen, KC; Marzabadi, MR; Mendez, I; Ping, XI; Santarelli, L; Saxe, MD; Swanson, CJ; Zhong, H | 1 |
| Hutson, PH; Murray, F | 1 |
| Barzó, P; Janka, Z; Kálmán, J; Sas, K; Szakács, R | 1 |
| Chidori, S; Egashira, N; Fujiwara, M; Hasebe, N; Higashihara, F; Iwasaki, K; Koushi, E; Matsuda, T; Mishima, K; Nishimura, R; Oishi, R | 1 |
| Itakura, C; Katayama, M; Niimi, K; Takahashi, E | 1 |
| Bruno, G; Lenzi, GL; Talarico, G; Tosto, G | 1 |
| Kundlik, ML; Pandya, A; Patel, CN; Patel, DM; Prajapati, S; Shah, HJ; Subbaiah, G; Suhagia, BN; Suhagiya, BN | 1 |
| Bouchez, G; Brocco, M; Dekeyne, A; Di Cara, B; Gannon, RL; Gobert, A; Lejeune, F; Millan, MJ | 1 |
| Hertel, A; Kiessling, B; Nikisch, G; Wiedemann, G | 1 |
| Bourin, M; Chenu, F; David, DJ; Gardier, AM; Le Maître, E; Leroux-Nicollet, I | 1 |
| Bosker, FJ; Cremers, TI; den Boer, JA; Folgering, JH; Gladkevich, AV; Schmidt, A; Sprouse, J; van der Hart, MC; Westerink, BH | 1 |
| Aznar, S; Knudsen, GM; Licht, CL; Marcussen, AB; Overstreet, DH; Wegener, G | 1 |
| Aznar, S; Chourbaji, S; Gass, P; Kirkegaard, L; Knudsen, GM; Licht, CL; Zueger, M | 1 |
| Baaré, WF; Erritzoe, D; Gillings, N; Hasselbalch, SG; Knudsen, GM; Madsen, K; Marner, L; Svarer, C | 1 |
| Debonnel, G; Du, J; Haddjeri, N; Lucas, G; Mnie-Filali, O; Piñeyro, G; Romeas, T | 1 |
| Aznar, S; El-Sayed, M; Elvang, AB; Ettrup, A; Holm, P; Klein, AB; Knudsen, GM; Mikkelsen, JD; Santini, MA; Stensbøl, TB | 1 |
| Greenway, LL; Kuppuswamy, PS; Lauterbach, EC | 1 |
| Cremers, TI; Hofland, CM; Kleijn, J; Westerink, BH | 1 |
| Begemann, MJ; Leucht, S; Sommer, IE; Temmerman, A | 1 |
| Furr, A; Lapiz-Bluhm, MD; Morilak, DA | 1 |
| Alexander, RC; Bifone, A; Dawson, GR; Dourish, CT; Favaron, E; Fernandes, S; Fiore, M; Goodwin, GM; Harmer, CJ; Parsons, E; Poggesi, I; Zucchetto, M | 1 |
| Callado, LF; Gonzalez-Lira, V; Herrera-Marschitz, M; Horrillo, I; Meana, JJ; Ortega, JE | 1 |
| Bronson, JJ; Davis, CD; Gillman, KW; Lelas, S; Li, YW; Lodge, NJ; Macor, JE; Molski, TF; Newberry, KS; Newton, AE; Parker, MF; Pieschl, RL; Taber, MT; Wallace-Boone, TL | 1 |
| Brański, P; Pałucha-Poniewiera, A; Pilc, A; Stachowicz, K; Sławińska, A; Wierońska, JM | 1 |
| Cummings, J; Zhong, K | 1 |
| Kawatani, M; Koyama, Y; Matsumoto-Miyai, K; Shimada, S; Shinzawa, E; Yamada, E; Yoshizumi, M | 1 |
| Oniszczuk, A; Poleszak, E; Serefko, A; Stasiuk, W; Świąder, K; Szopa, A; Wlaź, P; Wośko, S; Wyska, E | 1 |
| Chen, C; Ma, L; Shen, S; Wen, C; Yang, J | 1 |
| Åhs, F; Appel, L; Bani, M; Bettica, P; Fredrikson, M; Frick, A; Furmark, T; Jonasson, M; Långström, B; Lubberink, M; Merlo Pich, E; Wahlstedt, K | 1 |
| Berchtold, C; Briellmann, TA; Dussy, FE; Hamberg, C; Hangartner, S; Scherer, U; Schlotterbeck, G; Wyler, D | 1 |
| De Simone, A; Höfner, G; Neiens, P; Wanner, KT | 1 |
| Berrocoso, E; Meana, JJ; Mollinedo-Gajate, I; Ortega, JE; Perez-Palomar, B | 1 |
| Allmendinger, L; De Simone, A; Höfner, G; Neiens, P; Ramershoven, A; Wanner, KT | 1 |
| Deriha, K; Furuse, K; Hashiguchi, H; Hashimoto, E; Ishii, T; Kawanishi, C; Kigawa, Y; Shiraishi, M; Tayama, M; Ukai, W | 1 |
| Foster Olive, M; Gipson, CD; Leyrer-Jackson, JM; McCallum, J; Piña, JA | 1 |
| Akhondzadeh, S; Hashemi, MG; Hoobehfekr, S; Kashefinejad, S; Moghaddam, HS; Pirmoradi, MM; Poopak, A; Sakenian, A; Shalbafan, M; Yarahmadi, M | 1 |
| Andreasen, JT; Kristensen, JL; Odland, AU | 1 |
5 review(s) available for citalopram and piperidines
| Article | Year |
|---|---|
Biochemical pharmacology of the serotonin system.
Topics: Alanine; Brain; Citalopram; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Neurons; Oximes; p-Chloroamphetamine; Paroxetine; Piperidines; Propylamines; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Synapses; Tetrabenazine; Zimeldine | 1986 |
Therapeutic effects of serotonin uptake inhibitors in depression.
Topics: 5-Hydroxytryptophan; Alanine; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Imipramine; Oximes; Paroxetine; Piperidines; Propylamines; Serotonin; Serotonin Antagonists; Trazodone; Zimeldine | 1986 |
Medication treatments for panic disorder and social phobia.
Topics: Antidepressive Agents, Tricyclic; Benzamides; Benzodiazepines; Citalopram; Clinical Trials as Topic; Clomipramine; Clonazepam; Dose-Response Relationship, Drug; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Piperidines; Recurrence; Selective Serotonin Reuptake Inhibitors; Social Behavior Disorders | 1998 |
Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review.
Topics: Antipsychotic Agents; Brief Psychiatric Rating Scale; Citalopram; Clozapine; Dioxoles; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Fructose; Humans; Lamotrigine; Piperidines; Psychiatric Status Rating Scales; Psychotropic Drugs; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride; Topiramate; Treatment Outcome; Triazines | 2012 |
Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease.
Topics: Alzheimer Disease; Apathy; Citalopram; Clinical Trials as Topic; Cognition Disorders; Humans; Mental Disorders; Piperidines; Research Design; Therapies, Investigational; Treatment Outcome; Urea | 2015 |
8 trial(s) available for citalopram and piperidines
| Article | Year |
|---|---|
Diagnostic and therapeutic value of testing stimulation of thyroid-stimulating hormone by thyrotropin-releasing hormone in 100 depressed patients.
Topics: Adult; Aged; Bipolar Disorder; Citalopram; Depressive Disorder; Female; Humans; Male; Maprotiline; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Serotonin Antagonists; Thyrotropin; Thyrotropin-Releasing Hormone | 1990 |
Dexamethasone suppression test and the response to antidepressant depending on their central monoaminergic action in major depression.
Topics: Adult; Aged; Anthracenes; Citalopram; Depressive Disorder; Dexamethasone; Female; Humans; Male; Maprotiline; Middle Aged; Piperidines; Propylamines | 1987 |
Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Behavioral Symptoms; Citalopram; Dementia; Donepezil; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Indans; Male; Perphenazine; Piperidines; Placebos; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2002 |
Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo.
Topics: Adult; Anxiety; Cerebrovascular Circulation; Citalopram; Double-Blind Method; Female; Humans; Male; Neurokinin-1 Receptor Antagonists; Phobic Disorders; Piperidines; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Temporal Lobe; Tetrazoles | 2005 |
A rapid and specific approach for direct measurement of donepezil concentration in human plasma by LC-MS/MS employing solid-phase extraction.
Topics: Adult; Anticoagulants; Cholinesterase Inhibitors; Chromatography, Liquid; Citalopram; Donepezil; Drug Stability; Humans; Indans; Linear Models; Male; Piperidines; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2009 |
Combined NK₁ antagonism and serotonin reuptake inhibition: effects on emotional processing in humans.
Topics: Acetamides; Adult; Antidepressive Agents; Citalopram; Double-Blind Method; Emotions; Facial Expression; Humans; Male; Memory; Neurokinin-1 Receptor Antagonists; Perception; Piperidines; Recognition, Psychology; Selective Serotonin Reuptake Inhibitors; Young Adult | 2013 |
Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder.
Topics: Adult; Amygdala; Anti-Anxiety Agents; Cerebrovascular Circulation; Citalopram; Double-Blind Method; Female; Humans; Kinetics; Male; Neurokinin-1 Receptor Antagonists; Phobia, Social; Piperidines; Positron-Emission Tomography; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Social Environment; Stress, Psychological; Tetrazoles | 2016 |
Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Piperidines; Selective Serotonin Reuptake Inhibitors; Time Factors | 2021 |
64 other study(ies) available for citalopram and piperidines
| Article | Year |
|---|---|
[3H]citalopram binding to brain and platelet membranes of human and rat.
Topics: Animals; Binding Sites; Blood Platelets; Brain; Carrier Proteins; Cell Membrane; Citalopram; Humans; Imipramine; Kinetics; Neurons; Paroxetine; Piperidines; Rats; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Temperature; Thermodynamics | 1991 |
Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
Topics: Animals; Blood Platelets; Brain; Carrier Proteins; Cell Membrane; Citalopram; Half-Life; Humans; Imipramine; In Vitro Techniques; Membrane Proteins; Paroxetine; Piperidines; Rats; Serotonin Plasma Membrane Transport Proteins | 1991 |
No crossover reactions to citalopram or paroxetine among patients hypersensitive to zimeldine.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Combined Modality Therapy; Depressive Disorder; Drug Hypersensitivity; Female; Follow-Up Studies; Humans; Liver Function Tests; Male; Paroxetine; Piperidines; Serotonin Antagonists; Zimeldine | 1991 |
Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.
Topics: Adolescent; Adult; Aged; Binding, Competitive; Biological Transport; Brain; Citalopram; Female; Humans; Imipramine; Kinetics; Male; Membranes; Middle Aged; Organ Specificity; Paroxetine; Piperidines; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1990 |
Serotonergic and catecholaminergic reuptake inhibitors have opposite effects on the ultrasonic isolation calls of rat pups.
Topics: Animals; Body Temperature; Catecholamines; Citalopram; Clomipramine; Desipramine; Flumazenil; Mazindol; Motor Activity; Naltrexone; Nortriptyline; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Stress, Psychological; Ultrasonics; Vocalization, Animal | 1990 |
Inhibitory and regulatory binding sites on the rat brain serotonin transporter: molecular weight of the [3H]paroxetine and [3H]citalopram binding proteins.
Topics: Animals; Biological Transport, Active; Brain; Carrier Proteins; Citalopram; Half-Life; In Vitro Techniques; Kinetics; Models, Biological; Molecular Weight; Paroxetine; Piperidines; Rats; Receptors, Serotonin | 1990 |
Interaction between serotonin uptake inhibitors and alpha-2 adrenergic heteroreceptors in the rat hypothalamus.
Topics: Animals; Brimonidine Tartrate; Citalopram; Fenclonine; Hypothalamus; In Vitro Techniques; Male; Norepinephrine; Paroxetine; Piperidines; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1990 |
High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue.
Topics: Aged; Aged, 80 and over; Binding, Competitive; Brain; Citalopram; Female; Humans; Kinetics; Male; Middle Aged; Paroxetine; Piperidines; Receptors, Serotonin | 1989 |
Drug inhibition indicates a single-site model of the 5-HT uptake site/antidepressant binding site in rat and human brain.
Topics: Aged; Animals; Antidepressive Agents; Binding Sites; Brain; Citalopram; Clomipramine; Humans; In Vitro Techniques; Male; Middle Aged; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin | 1989 |
A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
Topics: Animals; Antidepressive Agents, Tricyclic; Binding Sites; Binding, Competitive; Biological Transport; Cerebral Cortex; Citalopram; Dose-Response Relationship, Drug; Ethylmaleimide; Fluoxetine; Imipramine; Male; Neurons; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Sodium | 1989 |
Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
Topics: 5-Methoxytryptamine; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Citalopram; Electric Stimulation; Fenclonine; Hypothalamus; Imipramine; Lysergic Acid Diethylamide; Male; Methiothepin; Neurotransmitter Agents; Pargyline; Paroxetine; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin | 1985 |
Biochemical and pharmacological tests for the prediction of ability of monoamine uptake blockers to inhibit the uptake of noradrenaline in-vivo: the effects of desipramine, maprotiline, femoxetine and citalopram.
Topics: Animals; Apomorphine; Body Temperature; Brain; Citalopram; Desipramine; Male; Maprotiline; Mice; Monoamine Oxidase Inhibitors; Norepinephrine; Piperidines; Propylamines; Reserpine; Serotonin Antagonists; Thyrotropin-Releasing Hormone; Tyramine | 1987 |
Effects of antidepressant drug combinations on cortical 5-HT2 receptors and wet-dog shakes in rats.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Carbidopa; Cerebral Cortex; Citalopram; Drug Interactions; Fenfluramine; Male; Methoxydimethyltryptamines; Paroxetine; Phenelzine; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Reflex; Serotonin; Time Factors | 1985 |
Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes.
Topics: Animals; Antidepressive Agents; Binding Sites; Binding, Competitive; Blood Platelets; Brain; Cell Membrane; Citalopram; Imipramine; In Vitro Techniques; Kinetics; Paroxetine; Piperidines; Propylamines; Rats; Serotonin; Serotonin Antagonists; Synaptic Membranes | 1985 |
High- and low-affinity binding of [3H]imipramine in rat hypothalamus.
Topics: Amitriptyline; Animals; Citalopram; Clomipramine; Cyclopropanes; Hypothalamus; Imipramine; Kinetics; Male; Milnacipran; Paroxetine; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Sodium | 1986 |
Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat.
Topics: Animals; Cerebral Cortex; Citalopram; Clomipramine; Clorgyline; Kinetics; Male; Membranes; Monoamine Oxidase Inhibitors; Paroxetine; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Selegiline; Serotonin | 1987 |
Characterization of [3H]paroxetine binding in rat brain.
Topics: Animals; Binding, Competitive; Brain; Cell Membrane; Cerebral Cortex; Citalopram; Fluoxetine; Imipramine; Male; Paroxetine; Peptide Hydrolases; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tritium | 1988 |
Dissociation kinetics of [3H]paroxetine binding to rat brain consistent with a single-site model of the antidepressant binding/5-hydroxytryptamine uptake site.
Topics: Animals; Brain; Cell Membrane; Citalopram; Clomipramine; Imipramine; Kinetics; Male; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Zimeldine | 1988 |
Amitriptyline and femoxetine, but not clomipramine or citalopram, antagonize hyperthermia induced by directly acting 5-hydroxytryptamine-like drugs in heat adapted rats.
Topics: Adaptation, Physiological; Amitriptyline; Animals; Body Temperature; Citalopram; Clomipramine; Dose-Response Relationship, Drug; Hot Temperature; Male; Piperazines; Piperidines; Propylamines; Quipazine; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists | 1984 |
Salivation after single-doses of the new antidepressants femoxetine, mianserin and citalopram. A cross-over study.
Topics: Adolescent; Adult; Antidepressive Agents; Citalopram; Dibenzazepines; Female; Flupenthixol; Humans; Male; Mianserin; Nortriptyline; Piperidines; Propylamines; Random Allocation; Salivation; Serotonin Antagonists | 1984 |
Antidepressants and serotonin neurons of the raphe.
Topics: Animals; Antidepressive Agents, Tricyclic; Benzofurans; Brain Stem; Citalopram; Clomipramine; Ethers; Fluvoxamine; Imipramine; Indoles; Locus Coeruleus; Male; Microscopy, Fluorescence; Norepinephrine; Oximes; Piperidines; Propylamines; Raphe Nuclei; Rats; Receptors, Serotonin; Serotonin | 1981 |
Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
Topics: 1-Naphthylamine; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Analysis of Variance; Animals; Behavior, Animal; Brain; Citalopram; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Fluvoxamine; Male; Mice; Paroxetine; Penbutolol; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sertraline; Synaptosomes | 1994 |
O-526, a piperidine analog of GBR 12909, retains high affinity for the dopamine transporter in monkey caudate-putamen.
Topics: Animals; Carrier Proteins; Caudate Nucleus; Citalopram; Cocaine; Dopamine Plasma Membrane Transport Proteins; In Vitro Techniques; Macaca fascicularis; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Piperazines; Piperidines; Protein Binding; Putamen; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1994 |
Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat.
Topics: 1-Naphthylamine; Animals; Behavior, Animal; Chlorpromazine; Citalopram; Fluoxetine; Fluvoxamine; Guanidines; Haloperidol; Male; Microinjections; Motor Activity; Paroxetine; Piperidines; Posture; Rats; Rats, Sprague-Dawley; Receptors, sigma; Red Nucleus; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
Topics: Animals; Carrier Proteins; Cell Line; Citalopram; Cloning, Molecular; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Design; Humans; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Structure; Nerve Tissue Proteins; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Serotonin; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Transfection | 1998 |
Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Dose-Response Relationship, Drug; Extracellular Space; Fluorobenzenes; Fluoxetine; Frontal Lobe; Male; Morpholines; p-Chloroamphetamine; Piperidines; Rats; Rats, Wistar; Serotonin; Serotonin Agents; Serotonin Antagonists; Synaptosomes; Tritium; Venlafaxine Hydrochloride | 2000 |
Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Citalopram; Cyclohexanols; Dose-Response Relationship, Drug; Extracellular Space; Fluorobenzenes; Fluoxetine; Frontal Lobe; Male; Morpholines; Norepinephrine; Piperidines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Venlafaxine Hydrochloride | 2000 |
Behavioral and neurochemical effects of anpirtoline and citalopram in isolated and group housed mice.
Topics: Aggression; Animals; Citalopram; Dopamine; Housing, Animal; Male; Mice; Piperidines; Pyridines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Social Behavior; Social Isolation | 2001 |
Rational design and synthesis of novel 2,5-disubstituted cis- and trans-piperidine derivatives exhibiting differential activity for the dopamine transporter.
Topics: Benzhydryl Compounds; Brain; Carrier Proteins; Citalopram; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Design; Drug Evaluation, Preclinical; Isomerism; Magnetic Resonance Spectroscopy; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Piperidines; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship | 2001 |
The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
Topics: Animals; Autoreceptors; Cerebral Cortex; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Guinea Pigs; Hypothalamus; Indoles; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Piperidines; Piperidones; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Presynaptic; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Species Specificity; Spiro Compounds; Subcellular Fractions; Triazoles; Tritium; United Kingdom | 2004 |
The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive-aggressive dog, as measured with 123I-5-I-R91150 SPECT.
Topics: Aggression; Animals; Behavior, Animal; Brain; Citalopram; Dogs; Impulsive Behavior; Piperidines; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2005 |
alpha(2)-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Amphetamines; Animals; Bridged Bicyclo Compounds, Heterocyclic; Brimonidine Tartrate; Citalopram; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Idazoxan; In Vitro Techniques; Locus Coeruleus; Male; Methiothepin; Naloxone; Narcotic Antagonists; Neurons; Norepinephrine; Oxazines; Piperazines; Piperidines; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Opioid, mu; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Thiophenes | 2005 |
Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Antidepressive Agents; Citalopram; Depressive Disorder; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Escape Reaction; Male; Mice; Neurokinin-1 Receptor Antagonists; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Swimming; Tetrazoles | 2006 |
Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocam
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimetabolites; Anxiety; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Citalopram; Drug Evaluation, Preclinical; Feeding Behavior; Hippocampus; Imipramine; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Motor Activity; Neurons; Piperidines; Receptors, Somatostatin; Selective Serotonin Reuptake Inhibitors; X-Rays | 2007 |
Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists.
Topics: Amitriptyline; Analysis of Variance; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Citalopram; Fluorobenzenes; Hippocampus; Imipramine; Indoles; Male; Mice; Piperazines; Piperidines; Proto-Oncogene Proteins c-bcl-2; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sulfonamides | 2007 |
[Amnesic syndrome following lesion of the fornix or does reversible Korsakow's syndrome exist?].
Topics: Amnesia, Anterograde; Citalopram; Donepezil; Female; Fornix, Brain; Humans; Indans; Intracranial Aneurysm; Korsakoff Syndrome; Middle Aged; Neurosurgical Procedures; Nootropic Agents; Piperidines; Risperidone; Rupture, Spontaneous; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2007 |
Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Brain; Citalopram; Dose-Response Relationship, Drug; Dronabinol; Injections, Intraperitoneal; Male; Mice; Motor Activity; Phenols; Piperazines; Piperidines; Psychotropic Drugs; Pyrazoles; Pyridines; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Rimonabant; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Succinimides; Sulfonamides; Swimming | 2008 |
Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Mice; Mice, Inbred CBA; Models, Animal; Morpholines; Motor Activity; Nomifensine; Piperidines; Pyrazoles; Reboxetine; Receptor, Cannabinoid, CB1; Rimonabant; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 2008 |
Effect of citalopram in treating hypersexuality in an Alzheimer's disease case.
Topics: Alzheimer Disease; Brain; Citalopram; Cognition Disorders; Disease Progression; Donepezil; Fluorodeoxyglucose F18; Humans; Indans; Male; Memory Disorders; Middle Aged; Mood Disorders; Nootropic Agents; Obsessive-Compulsive Disorder; Piperidines; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome | 2008 |
Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Brain; Citalopram; Cricetinae; Dopamine; Drug Synergism; Fluoxetine; Gerbillinae; Isoindoles; Male; Mesocricetus; Mice; Neurokinin-1 Receptor Antagonists; Neurons; Norepinephrine; Piperidines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Tetrazoles | 2009 |
[Familial Alzheimer's disease with presenilin 2 N141I mutation. A case report].
Topics: Adult; Alzheimer Disease; Antidepressive Agents, Second-Generation; Brain; Citalopram; Codon; Donepezil; Electroencephalography; Female; Fluorodeoxyglucose F18; Humans; Indans; Mutation, Missense; Neuropsychological Tests; Nootropic Agents; Pedigree; Piperidines; Positron-Emission Tomography; Presenilin-2; Radiopharmaceuticals | 2008 |
Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system.
Topics: 5,7-Dihydroxytryptamine; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Citalopram; Dopamine; Male; Mice; Oxadiazoles; Piperazines; Piperidines; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2008 |
Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors.
Topics: Action Potentials; Analysis of Variance; Animals; Brain; Chromatography, High Pressure Liquid; Citalopram; Drug Interactions; Electrochemistry; Male; Microdialysis; Neurons; Piperazines; Piperidines; Pyrazoles; Pyridines; Pyrrolidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin Agents; Tetrahydronaphthalenes; Tosyl Compounds; Wakefulness | 2009 |
The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration.
Topics: Animals; Antidepressive Agents, Second-Generation; Autoradiography; Brain; Citalopram; Depression; Disease Models, Animal; Fenclonine; Fenfluramine; Fluorobenzenes; Freezing Reaction, Cataleptic; Male; Paroxetine; Piperidines; Protein Binding; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT4; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Swimming; Time Factors; Tritium | 2009 |
Changes in 5-HT4 receptor and 5-HT transporter binding in olfactory bulbectomized and glucocorticoid receptor heterozygous mice.
Topics: Animals; Autoradiography; Brain Chemistry; Citalopram; Image Processing, Computer-Assisted; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Olfactory Bulb; Piperidines; Protein Binding; Receptors, Glucocorticoid; Receptors, Serotonin, 5-HT4; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2010 |
Brain imaging of serotonin 4 receptors in humans with [11C]SB207145-PET.
Topics: Adult; Aging; Brain; Brain Mapping; Citalopram; Corpus Striatum; Female; Hippocampus; Humans; Male; Middle Aged; Piperidines; Positron-Emission Tomography; Prefrontal Cortex; Receptors, Serotonin, 5-HT4; Selective Serotonin Reuptake Inhibitors; Sex Characteristics; Young Adult | 2010 |
Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
Topics: Action Potentials; Aniline Compounds; Animals; Antidepressive Agents; Benzofurans; CA3 Region, Hippocampal; Citalopram; Cyclic AMP Response Element-Binding Protein; Drug Synergism; Fluvoxamine; Male; Motor Activity; Neurons; Phosphorylation; Piperazines; Piperidines; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT4 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2010 |
Plaque deposition dependent decrease in 5-HT2A serotonin receptor in AbetaPPswe/PS1dE9 amyloid overexpressing mice.
Topics: Aging; Amphetamines; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Autoradiography; Citalopram; Data Interpretation, Statistical; Fluorobenzenes; Genes, fos; Head Movements; Humans; In Situ Hybridization; Indicators and Reagents; Male; Mice; Mice, Transgenic; Piperidines; Plaque, Amyloid; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 2010 |
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.
Topics: Aged; Amantadine; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Catatonia; Citalopram; Clinical Trials as Topic; Dibenzothiazepines; Donepezil; Dopamine Agents; Excitatory Amino Acid Antagonists; Female; Frontotemporal Dementia; Humans; Hypnotics and Sedatives; Indans; Lorazepam; Memantine; Middle Aged; Nootropic Agents; Piperazines; Piperidines; Pramipexole; Quetiapine Fumarate; Quinolones; Selective Serotonin Reuptake Inhibitors | 2010 |
CB-1 receptors modulate the effect of the selective serotonin reuptake inhibitor, citalopram on extracellular serotonin levels in the rat prefrontal cortex.
Topics: Animals; Benzoxazines; Cannabinoid Receptor Modulators; Cannabinoids; Citalopram; Drug Interactions; Extracellular Fluid; Male; Morpholines; Naphthalenes; Piperidines; Prefrontal Cortex; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Selective Serotonin Reuptake Inhibitors; Serotonin | 2011 |
5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Attention; beta-Cyclodextrins; Chronic Disease; Citalopram; Cognition; Fluorobenzenes; Male; Microinjections; Pharmaceutical Vehicles; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Reversal Learning; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Set, Psychology; Stress, Psychological | 2012 |
Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
Topics: Animals; Antidepressive Agents; Brain; Cannabinoid Receptor Antagonists; Citalopram; Dose-Response Relationship, Drug; Drug Synergism; Extracellular Fluid; Injections, Intraperitoneal; Kinetics; Locus Coeruleus; Male; Microdialysis; Piperidines; Prefrontal Cortex; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Serotonin; Synaptic Transmission | 2013 |
NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test.
Topics: Animals; Antidepressive Agents; Aprepitant; Citalopram; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Gerbillinae; HEK293 Cells; Humans; Immobility Response, Tonic; Male; Morpholines; Neurokinin-1 Receptor Antagonists; Piperidines; Prefrontal Cortex; Radioligand Assay; Receptors, Neurokinin-1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2013 |
The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent.
Topics: Animals; Antidepressive Agents; Citalopram; Diet; Excitatory Amino Acid Antagonists; Fenclonine; Fluoxetine; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Motor Activity; Piperidines; Receptors, Kainic Acid; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Thiazoles; Tryptophan | 2014 |
Serotonergic regulation of distention-induced ATP release from the urothelium.
Topics: Adenosine Triphosphate; Animals; Citalopram; Dioxanes; Male; Mice; Oxadiazoles; Piperazines; Piperidines; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin, 5-HT4; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Urinary Bladder; Urothelium | 2016 |
Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Fluoxetine; Imipramine; Mice; Motor Activity; Piperidines; Receptors, N-Methyl-D-Aspartate; Swimming; Treatment Outcome | 2016 |
Hepatotoxicity Associated with Donepezil in an Individual Taking Citalopram.
Topics: Aged, 80 and over; Alzheimer Disease; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Citalopram; Donepezil; Drug Therapy, Combination; Female; Humans; Indans; Nootropic Agents; Piperidines | 2016 |
An Acute Ocfentanil Fatality: A Case Report with Postmortem Concentrations.
Topics: Acetaminophen; Autopsy; Body Fluids; Calibration; Cannabinoids; Chromatography, High Pressure Liquid; Citalopram; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Male; Piperidines; Quetiapine Fumarate; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Young Adult | 2016 |
Simultaneous Multiple MS Binding Assays for the Dopamine, Norepinephrine, and Serotonin Transporters.
Topics: Benzhydryl Compounds; Binding Sites; Chromatography, Liquid; Citalopram; Dopamine Plasma Membrane Transport Proteins; Humans; Molecular Structure; Norepinephrine Plasma Membrane Transport Proteins; Piperidines; Reboxetine; Serotonin Plasma Membrane Transport Proteins; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2018 |
Serotonin 5-HT
Topics: Animals; Antidepressive Agents; Citalopram; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Exploratory Behavior; Locus Coeruleus; Male; Mice; Microdialysis; Norepinephrine; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 2018 |
Development and validation of an LC-ESI-MS/MS method for the quantification of D-84, reboxetine and citalopram for their use in MS Binding Assays addressing the monoamine transporters hDAT, hSERT and hNET.
Topics: Animals; Benzhydryl Compounds; Chromatography, Liquid; Citalopram; Humans; Morpholines; Piperidines; Protein Binding; Reboxetine; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Symporters; Tandem Mass Spectrometry | 2018 |
Antidepressant activities of escitalopram and blonanserin on prenatal and adolescent combined stress-induced depression model: Possible role of neurotrophic mechanism change in serum and nucleus accumbens.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Citalopram; Corticosterone; Depression; Disease Models, Animal; Female; Hippocampus; Male; Nucleus Accumbens; Piperazines; Piperidines; Pregnancy; Rats; Social Behavior; Swimming | 2019 |
Direct administration of ifenprodil and citalopram into the nucleus accumbens inhibits cue-induced nicotine seeking and associated glutamatergic plasticity.
Topics: Animals; Citalopram; Cues; Dendritic Spines; Drug-Seeking Behavior; Excitatory Amino Acid Antagonists; Extinction, Psychological; Glutamic Acid; Male; Neuronal Plasticity; Neurons; Nicotine; Nucleus Accumbens; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors; Self Administration | 2020 |
Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice.
Topics: Aminopyridines; Amphetamines; Animals; Behavior, Animal; Citalopram; Compulsive Behavior; Disease Models, Animal; Female; Fluorobenzenes; Indoles; Mice; Piperidines; Psilocybin; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists | 2021 |